New York State Common Retirement Fund
ORIC icon

New York State Common Retirement Fund’s Oric Pharmaceuticals ORIC Stock Holding History

New York State Common Retirement Fund’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Hold
18,429
– – ﹤0.01% 2373
2026
Q1 		$233K Hold
18,429
– – ﹤0.01% 2172
2025
Q4 		$151K Sell
18,429
-26,648
-59% -$307K ﹤0.01% 2415
2025
Q3 		$541K Buy
45,077
+27,285
+153% +$287K ﹤0.01% 1923
2025
Q2 		$181K Sell
17,792
-20,694
-54% -$139K ﹤0.01% 2293
2025
Q1 		$215K Buy
38,486
+22,257
+137% +$195K ﹤0.01% 2203
2024
Q4 		$131K Hold
16,229
– – ﹤0.01% 2485
2024
Q3 		$166K Hold
16,229
– – ﹤0.01% 2383
2024
Q2 		$115K Sell
16,229
-28,485
-64% -$255K ﹤0.01% 2683
2024
Q1 		$615K Buy
44,714
+35,144
+367% +$417K ﹤0.01% 1999
2023
Q4 		$88K Sell
9,570
-6,131
-39% -$44.3K ﹤0.01% 2801
2023
Q3 		$95K Buy
15,701
+401
+3% +$3.29K ﹤0.01% 2749
2023
Q2 		$119K Buy
+15,300
New +$86.9K ﹤0.01% 2713
2022
Q3 		– Sell
-283
Closed -$1K – 3401
2022
Q2 		$1K Sell
283
-19,300
-99% -$77K ﹤0.01% 3386
2022
Q1 		$105K Buy
19,583
+26
+0.1% +$234 ﹤0.01% 3006
2021
Q4 		$287K Sell
19,557
-4,145
-17% -$64.6K ﹤0.01% 2728
2021
Q3 		$496K Sell
23,702
-3,585
-13% -$72.7K ﹤0.01% 2468
2021
Q2 		$483K Buy
27,287
+5,787
+27% +$127K ﹤0.01% 2610
2021
Q1 		$527K Buy
21,500
+3,100
+17% +$98K ﹤0.01% 2427
2020
Q4 		$623K Buy
18,400
+10,400
+130% +$298K ﹤0.01% 2243
2020
Q3 		$200K Hold
8,000
– – ﹤0.01% 2644
2020
Q2 		$270K Buy
+8,000
New +$255K ﹤0.01% 2515

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

New York State Common Retirement Fund's ORIC Position: Q2 2026 in Review

New York State Common Retirement Fund held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 18,429 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2373.

New York State Common Retirement Fund first reported a position in ORIC in Q2 2020 and has held it in 22 quarters since. The position peaked at $623K in Q4 2020. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • New York State Common Retirement Fund held 18,429 shares of Oric Pharmaceuticals worth $200K as of Q2 2026.
  • New York State Common Retirement Fund left its Oric Pharmaceuticals share count unchanged in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2373 holding.
  • New York State Common Retirement Fund first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 22 quarters since.
  • New York State Common Retirement Fund's Oric Pharmaceuticals position peaked at $623K in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.